HCC surveillance after SVR in patients with F3/F4 fibrosis

GN Ioannou - Journal of hepatology, 2021 - Elsevier
HCV eradication by antiviral treatment reduces but does not eliminate HCC risk. Patients
with established cirrhosis require HCC surveillance “indefinitely” after sustained virologic …

HCC surveillance after SVR in patients with F3/F4 fibrosis.

GN Ioannou - 2021 - cabidigitallibrary.org
HCV eradication by antiviral treatment reduces but does not eliminate HCC risk. Patients
with established cirrhosis require HCC surveillance" indefinitely" after sustained virologic …

HCC surveillance after SVR in patients with F3/F4 fibrosis

GN Ioannou - Journal of Hepatology, 2021 - journal-of-hepatology.eu
HCV eradication by antiviral treatment reduces but does not eliminate HCC risk. Patients
with established cirrhosis require HCC surveillance" indefinitely" after sustained virologic …

HCC surveillance after SVR in patients with F3/F4 fibrosis

GN Ioannou - Journal of hepatology, 2021 - pubmed.ncbi.nlm.nih.gov
HCV eradication by antiviral treatment reduces but does not eliminate HCC risk. Patients
with established cirrhosis require HCC surveillance" indefinitely" after sustained virologic …

[PDF][PDF] HCC surveillance after SVR in patients with F3/F4 fibrosis

GN Ioannou - natap.org
HCV eradication by antiviral treatment reduces but does not eliminate HCC risk. Patients
with established cirrhosis require HCC surveillance “indefinitely” after sustained virologic …

[PDF][PDF] HCC surveillance after SVR in patients with F3/F4 fibrosis

GN Ioannou - natap.org
HCV eradication by antiviral treatment reduces but does not eliminate HCC risk. Patients
with established cirrhosis require HCC surveillance “indefinitely” after sustained virologic …

[引用][C] HCC surveillance after SVR in patients with F3/F4 fibrosis

GN Ioannou - Journal of Hepatology, 2021 - cir.nii.ac.jp

HCC surveillance after SVR in patients with F3/F4 fibrosis.

GN Ioannou - Journal of Hepatology, 2020 - europepmc.org
HCV eradication by antiviral treatment reduces but does not eliminate HCC risk. Patients
with established cirrhosis require HCC surveillance" indefinitely" after sustained virologic …

HCC surveillance after SVR in patients with F3/F4 fibrosis

GN Ioannou - Journal of Hepatology, 2021 - journal-of-hepatology.eu
HCV eradication by antiviral treatment reduces but does not eliminate HCC risk. Patients
with established cirrhosis require HCC surveillance" indefinitely" after sustained virologic …